Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients

Supportive Care in Cancer

Volumn 13, Issue 4, 2005, Pages 266-269

  Aisa, Yoshinobu ^a   Mori, Takehiko ^a   Kudo, Masumi ^b   Yashima, Tomoko ^b   Kondo, Sakiko ^b   Yokoyama, Akihiro ^a   Ikeda, Yasuo ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hematopoietic stem cell transplant; High dose melphalan; Oral cryotherapy; Stomatitis

Indexed keywords

CYCLOSPORIN A; CYTARABINE; FLUDARABINE; ICE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SARCOLYSIN; TACROLIMUS; WATER;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; EDEMA; ERYTHEMA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MOUTH ULCER; PRIORITY JOURNAL; RECIPIENT; STOMATITIS;

ANTINEOPLASTIC AGENTS, ALKYLATING; CRYOTHERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; MALE; MELPHALAN; MIDDLE AGED; STOMATITIS;

EID: 17744374486     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0726-y     Document Type: Article

References (11)

1. Cascinu S, Fedeli A, Fedeli SL, Catalano G (1994) Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil- induced stomatitis. Oral Oncol, Eur J Cancer 30B:234-236
2. Devine SM, Sanborn R, Jessoop E, Stock W, Huml M, Peace D, Wickrema A, Yassine M, Amin K. Thomason D, Chen Y-H, Devine H, Maningo M, van Besien K (2001) Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. Bone Marrow Transplant 28:557-562
3. Dumonet C, Sonnet A, Bastion Y, Salles G, Espinouse D, Coiffier B (1994) Prevention of high dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplant 3:492-494
4. Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R (2002) Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Bone Marrow Transplant 30:367-373
5. Gouyette A, Hartman O, Pico J-L (1986) Pharmacokinetics of high-dose melphalan in children and adults. Cancer Chemother Pharmacol 16:184-189
6. Kroger N, Schwerdrfeger R, Kiehl M, Sayer HG, Renges H, Zabelina T, Fehse B, Togel F, Wittkowsky G, Kuse R, Zander AR (2002) Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood 100:755-760
7. Kroger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, Renges H, Zabelina T, Fehse B, Ayuk F, Wittkowsky G, Schmitz N, Zander AR (2002) Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplant-related mortality. Blood 100:3919-3924
8. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Finck Gk, Johnson C, Goldberg RM (1991) Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452
9. Meloni G, Capria S, Proia A, Trisolini SM, Mandelli F (1996) Ice pops to prevent melphalan-induced stomatitis. Lancet 347:1691-1692
10. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, Lifsey D, Glaw KC, Stevens BA, Hatfield AK, Vaught NL, Bartel J, Pierson N (1993) A randomized clinical trial of two different durations of oral cryotherapy for prevention of fluorouracil-related stomatitis. Cancer 72:2234-2238
11. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 (Suppl 9):2026-2046